Skip to content
AI IntelligenceMay 4, 2026AI Intelligence
Article

Hoth Therapeutics received a delisting warning from Nasdaq.

The biotech company must comply with exchange rules or face removal. A risk warning for shareholders.

Data Cube AI EditorialSource: SEC EDGAR 8-K
01

Source Brief

Hoth Therapeutics received a delisting warning from Nasdaq. The biotech company must comply with exchange rules or face removal. A risk warning for shareholders.